🇺🇸 Acthrel in United States

FDA authorised Acthrel on 23 May 1996

Marketing authorisations

FDA — authorised 23 May 1996

  • Marketing authorisation holder: FERRING
  • Status: approved

FDA — authorised 23 May 1996

  • Application: BLA020162
  • Marketing authorisation holder: FERRING
  • Local brand name: ACTHREL
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

Acthrel in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Nephrology approved in United States

Frequently asked questions

Is Acthrel approved in United States?

Yes. FDA authorised it on 23 May 1996; FDA authorised it on 23 May 1996.

Who is the marketing authorisation holder for Acthrel in United States?

FERRING holds the US marketing authorisation.